Clinical Clearance of Actinic Keratoses with Tirbanibulin 1% Ointment: Evidence from a Meta-Analysis
Life · 13.08.2026 · 16 (8) · 1330
DOI: 10.3390/life16081330 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Life, online erschienen am 13.08.2026. Verfasst von Mircea Tampa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carol Davila University of Medicine and Pharmacy, University of Medicine and Pharmacy Carol Davila.
Abstract (Originalsprache)
Actinic keratoses (AKs) are skin conditions that arise from the proliferation of atypical keratinocytes and are considered precursors to cutaneous squamous cell carcinoma. There are several treatment options available, which can be categorized into two main groups: lesion-directed therapies and field-directed therapies. Tirbanibulin 1% ointment has emerged as a new treatment for AKs. We conducted a meta-analysis to evaluate the effectiveness of tirbanibulin by analyzing the rates of complete clearance (CC) and partial clearance (PC) in randomized controlled trials (RCTs) and real-world studies. Our search included four databases: PubMed, Google Scholar, Scopus, and Web of Science. After applying specific inclusion and exclusion criteria, we identified 11 study cohorts from 10 publications. The CC rate was reported in 10 of the 11 studies, involving a total of 2092 patients, with 874 CC events observed. This resulted in an overall pooled CC rate of 52.05% (95% CI: 42.43–61.52%). The PC rate was also reported in 10 of the 11 studies, involving a total of 2367 patients, with 1631 PC events recorded. This led to an overall pooled PC rate of 71.96% (95% CI: 64.89–78.09%). In conclusion, tirbanibulin 1% ointment has shown clinical effectiveness and should be considered a promising treatment for AKs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Department of Dermatology, 'Victor Babes' Clinical Hospital for Infectious Diseases, 030303 Bucharest, Romania.
- Department of Microbiology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Division of Dermatology, Department of Internal Medicine, School of Medicine, Walailak University, Nakhon Si Thammarat 80160, Thailand.
- Gastroenterology Department, Clinical Emergency Hospital of Bucharest, 014461 Bucharest, Romania.
- Department of Nephrology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
ORCID-Profile: Mircea Tampa, Weeratian Tawanwongsri, Ecaterina Rinja, Milena Tocut
Förderung
- Carol Davila University of Medicine and Pharmacy
- University of Medicine and Pharmacy Carol Davila
Zitieren
APA
Tampa, M., Matei, C., Mitran, M. I., Mitran, C. I., Tawanwongsri, W., Chiriac, P. L., Rinja, E., Ene, C. D., Nicolae, I., Tocut, M., & Georgescu, S. R. (2026). Clinical Clearance of Actinic Keratoses with Tirbanibulin 1% Ointment: Evidence from a Meta-Analysis. Life, 16(8), 1330. https://doi.org/10.3390/life16081330
Vancouver
Tampa M, Matei C, Mitran MI, Mitran CI, Tawanwongsri W, Chiriac PL, et al. Clinical Clearance of Actinic Keratoses with Tirbanibulin 1% Ointment: Evidence from a Meta-Analysis. Life. 2026;16(8):1330. doi:10.3390/life16081330
BibTeX
@article{Tampa2026,
author = {Tampa, Mircea and Matei, Clara and Mitran, Madalina Irina and Mitran, Cristina Iulia and Tawanwongsri, Weeratian and Chiriac, Paula Loredana and Rinja, Ecaterina and Ene, Corina Daniela and Nicolae, Ilinca and Tocut, Milena and Georgescu, Simona Roxana},
title = {Clinical Clearance of Actinic Keratoses with Tirbanibulin 1% Ointment: Evidence from a Meta-Analysis},
journal = {Life},
year = {2026},
volume = {16},
number = {8},
pages = {1330},
doi = {10.3390/life16081330}
}
EUVIMED